𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical experience with ultrasound thermotherapy

✍ Scribed by C. Marchal

Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
306 KB
Volume
30
Category
Article
ISSN
0041-624X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Preliminary clinical experience with las
Preliminary clinical experience with laser-induced interstitial thermotherapy in patients with hepatocellular carcinoma
✍ Christoph Bremer; Thomas Allkemper; Josef Menzel; Udo Sulkowski; Ernst Rummeny; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 647 KB

## Abstract The purpose of this preliminary study was to evaluate whether laser‐induced interstitial thermotherapy (LITT) may be used for palliative treatment of localized hepatocellular carcinomas (HCC). We applied LITT to two patients suffering from unresectable localized hepatocellular carcinoma

Initial clinical experience with a novel
Initial clinical experience with a novel low-profile integrated ultrasound-angioplasty cathether
✍ Stone, Gregg W. ;St. Goar, Frederick G. ;Linnemeier, Thomas J. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 502 KB

This report is the first clinical description of the use of a new iow-profile integrated ultrasound-angioplasty catheter (the Ora c l e Micro, Endosonics Corp.), which has recently been approved by the FDA for routine use during percutaneous transluminal coronary angiopiasty (PTCA). PTCA was perform

Numerical simulation of ultrasound-therm
Numerical simulation of ultrasound-thermotherapy combining nonlinear wave propagation with broadband soft-tissue absorption
✍ S Ginter πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 177 KB

Ultrasound (US) thermotherapy is used to treat tumours, located deep in human tissue, by heat. It features by the application of high intensity focused ultrasound (HIFU), high local temperatures of about 90 degrees C and short treating time of a few seconds. Dosage of the therapy remains a problem.

Clinical experience with the micronucleu
Clinical experience with the micronucleus assay
✍ Dr. Harinder S. Garewal; Lois Ramsey; George Kaugars; Jay Boyle πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 616 KB

Because of the logistical and practical problems that make cancer prevention trials using cancer incidence as an endpoint virtually impossible to conduct for the majority of cancer types, there is a desperate need for valid intermediate markers of cancer risk to serve as surrogate endpoints in chemo